featured
Atezolizumab in Metastatic TNBC: IMpassion130 and 131 Trials
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Atezolizumab in Metastatic Triple-Negative Breast Cancer: IMpassion130 and 131 Trials – How to Explain Different Results?
ESMO Open 2020 Nov 01;5(6)1-4, MA Franzoi, E de AzambujaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.